Enhancing Biomarker Evaluation & Innovating Organoid & AI Models to Test & Validate Patient Samples to Improve Response Rate, Efficacy & Success of Inflammatory Bowel Disease Therapies
Precision medicine is transforming the future of Crohn’s disease and ulcerative colitis. With breakthroughs in AI-driven analytics, multiomic integration, and biomarker-guided therapy design, the field is finally moving beyond symptom management toward truly personalized, durable remission.
In its 4th year, the Precision Medicine in Inflammatory Bowel Disease Summit united 50+ senior leaders across biopharma, translational science, and clinical development to accelerate the next generation of targeted IBD therapies.
2026's agenda explored AI-enabled drug discovery and multiomic use-cases with Takeda, brings exclusive insights from Abbvie and Spyre on combination therapy design, and tackles data challenges with Merck and Crohn’s & Colitis Foundation.
We were joined with leading minds from Johnson & Johnson, Sanofi, Xencor, Astellas, AstraZenecas and more to shape the next era of IBD treatment, where science, strategy, and innovation intersect to deliver smarter, faster, and more effective precision therapies for patients in need.
High quality topics and the speakers, which cover innovations about how to use AI for biomarker development, and other hot topics in Precision medicine in IBD
Yongli Dong, Principal Scientist, Abbvie
High quality of attendees. Breaks and networking was well organised and good length.
Neil Humphryes-Kirilov, Associate Director, Genomics, C4X Discovery
It was an intimate meeting with excellent representation from big pharma and biotech in the IBD space. I was able to have meaningful conversations with most attendees whether through round table discussions or social breaks.
Nicole Desch, Translational Biomarker Lead, Takeda Pharmaceutical
Explore the Previous Event Guide
- 50+ senior biopharma leaders driving precision innovation
- 2 deep-dive workshop sessions covering artificial intelligence and combination therapy design
- Exclusive insights into cutting-edge organoid, multiomic, and computational models
- Unparalleled networking opportunities with decision-makers advancing IBD pipelines
- Discover breakthrough strategies shaping the next generation of personalized care
2026 Speakers
Attending Companies Included
Explore Related Events
Explore the Agenda
Discover cutting-edge sessions on AI, biomarkers, and combination therapies redefining IBD precision medicine.
Partner With Us
Connect with senior biopharma leaders seeking innovative tools, models, and data solutions to advance IBD pipelines.
Join Biopharma Experts
Network with industry pioneers shaping the next generation of personalized Crohn’s and Colitis treatments.